Anthropological, Socio-cultural and Psychological Surgeons' Factors in Oncology and Brakes for Evaluation of Innovations
Launched by INSTITUT CLAUDIUS REGAUD · May 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how different factors—like the background, culture, and psychology of surgeons—can affect how new surgical methods and technologies are evaluated in oncology (cancer surgery). Even though surgery often benefits from innovative techniques, the process of assessing their effectiveness and safety is crucial. The aim of this study is to better understand these influences so that new surgical innovations can be introduced more effectively.
The trial is currently recruiting participants who are surgeons specializing in oncology and practicing in France. If you are a surgeon in this field, you may be eligible to participate as long as you have an accessible email address through one of the participating organizations. As a participant, you can expect to share your experiences and perspectives, which will contribute to improving how new surgical techniques are evaluated. There are no specific exclusions for this trial, making it open for all qualifying surgeons.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Surgeon practising oncology in France.
- • E-mail address accessible via one of the companies/cooperating groups that have agreed to participate in the project
- Exclusion Criteria:
- • None
About Institut Claudius Regaud
Institut Claudius Regaud is a leading cancer research and treatment center based in Toulouse, France, renowned for its commitment to advancing oncology through innovative clinical trials and multidisciplinary approaches. As a prominent sponsor of clinical research, the institute focuses on developing and evaluating cutting-edge therapies, enhancing patient care, and improving outcomes in cancer treatment. With a strong emphasis on collaboration and scientific excellence, Institut Claudius Regaud brings together a team of expert researchers, oncologists, and healthcare professionals dedicated to translating laboratory discoveries into effective clinical applications, thereby contributing significantly to the global fight against cancer.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toulouse, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported